Cargando…

BST2 promotes growth and induces gefitinib resistance in oral squamous cell carcinoma via regulating the EGFR pathway

INTRODUCTION: Gefitinib, well known as a new antitumor agent, has been applied in various cancers such as oral squamous cell carcinoma (OSCC). However, most patients eventually acquire resistance to gefitinib, and the molecular mechanism of gefitinib resistance is not well described. Bone marrow str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Huang, Zhang, Lianping, Wang, Shufang, Qian, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Basic Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641506/ https://www.ncbi.nlm.nih.gov/pubmed/34900059 http://dx.doi.org/10.5114/aoms.2019.86183

Ejemplares similares

The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro
por: Khalil, Ashraf, et al.
Publicado: (2017)

BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway
por: Shan, Fayu, et al.
Publicado: (2023)

Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway
por: Hu, Dong-Xin, et al.
Publicado: (2022)

Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways
por: Huang, Yanjun, et al.
Publicado: (2018)

Long non-coding RNA LINC01296 promotes progression of oral squamous cell carcinoma through activating the MAPK/ERK signaling pathway via the miR-485-5p/PAK4 axis
por: Zhang, Shuangyue, et al.
Publicado: (2019)

Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk
por: Peng, Mei, et al.
Publicado: (2016)

LPCAT1 promotes gefitinib resistance via upregulation of the EGFR/PI3K/AKT signaling pathway in lung adenocarcinoma
por: Ding, Jianghua, et al.
Publicado: (2022)

Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma
por: Parikh, Anuraag, et al.
Publicado: (2020)

Prognostic role of CD11b(+) myeloid-derived suppressor cells in oral squamous cell carcinoma
por: Jiang, Yue, et al.
Publicado: (2021)

Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
por: Pan, Yong-hong, et al.
Publicado: (2018)

TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway
por: Xiao, Zhangxian, et al.
Publicado: (2023)

Chloroquine promotes gefitinib-induced apoptosis by inhibiting protective autophagy in cutaneous squamous cell carcinoma
por: Ou, Chengshan, et al.
Publicado: (2019)

Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway
por: Qi, Bo, et al.
Publicado: (2017)

Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A
por: Johnson, Tara L., et al.
Publicado: (2010)

Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death
por: Britain, Colleen M., et al.
Publicado: (2018)

Androgen receptor promotes oral squamous cell carcinoma cell migration by increasing EGFR phosphorylation
por: Liu, Xin, et al.
Publicado: (2019)

Fibromodulin overexpression drives oral squamous cell carcinoma via activating downstream EGFR signaling
por: Xia, Lingyun, et al.
Publicado: (2023)

Adrenomedullin Up-regulates the Expression of Vascular Endothelial Growth Factor in Epithelial Ovarian Carcinoma Cells via JNK/AP-1 Pathway
por: Chen, Qingqing, et al.
Publicado: (2015)

RNF128 Promotes Invasion and Metastasis Via the EGFR/MAPK/MMP-2 Pathway in Esophageal Squamous Cell Carcinoma
por: Gao, Jing, et al.
Publicado: (2019)

Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS
por: He, Feng, et al.
Publicado: (2016)

Targeted Co-Delivery of Gefitinib and Rapamycin by Aptamer-Modified Nanoparticles Overcomes EGFR-TKI Resistance in NSCLC via Promoting Autophagy
por: Liu, Yuhong, et al.
Publicado: (2022)

Gefitinib for Epidermal Growth Factor Receptor Activated Osteoarthritis Subpopulation Treatment
por: Sun, Heng, et al.
Publicado: (2018)

Overexpression of RAB27A in Oral Squamous Cell Carcinoma Promotes Tumor Migration and Invasion via Modulation of EGFR Membrane Stability
por: Huang, Jue, et al.
Publicado: (2023)

Tests Of The Service Request Of The BST
por: Baribaud, Guy, et al.
Publicado: (1991)

Formin-like 3 regulates RhoC/FAK pathway and actin assembly to promote cell invasion in colorectal carcinoma
por: Zeng, Yuan-Feng, et al.
Publicado: (2018)

Epidermal Growth Factor Receptor (EGFR)-RAS Signaling Pathway in Penile Squamous Cell Carcinoma
por: Gou, Hong-Feng, et al.
Publicado: (2013)

Gefitinib-mediated apoptosis is enhanced via inhibition of autophagy by chloroquine diphosphate in cutaneous squamous cell carcinoma cells
por: Wang, Jianyu, et al.
Publicado: (2019)

Dioscin inhibiting EGFR-mediated Survivin expression promotes apoptosis in oral squamous cell carcinoma cells
por: Li, Ming, et al.
Publicado: (2023)

KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling
por: Hao, Wei-Wei, et al.
Publicado: (2022)

Hsa_circ_0005379 regulates malignant behavior of oral squamous cell carcinoma through the EGFR pathway
por: Su, Wen, et al.
Publicado: (2019)

STAT3-mediated activation of mitochondrial pathway contributes to antitumor effect of dihydrotanshinone I in esophageal squamous cell carcinoma cells
por: Qi, Ming-Ming, et al.
Publicado: (2021)

Kinectin1 depletion promotes EGFR degradation via the ubiquitin-proteosome system in cutaneous squamous cell carcinoma
por: Ma, Ji, et al.
Publicado: (2021)

Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib
por: Yuan, Ying, et al.
Publicado: (2012)

The Role of EGFR/ERK/ELK-1 MAP Kinase Pathway in the Underlying Damage to Diabetic Rat Skin
por: Ge, Xinhong, et al.
Publicado: (2013)

Mitochondrial pathway of the lysine demethylase 5C inhibitor CPI-455 in the Eca-109 esophageal squamous cell carcinoma cell line
por: Xue, Xiao-Jie, et al.
Publicado: (2021)

Linc01014 regulates gefitinib resistance in oesophagus cancer via EGFR‐PI3K‐AKT‐mTOR signalling pathway
por: Fu, Xiao, et al.
Publicado: (2019)

N-linked glycoproteomic profiling in esophageal squamous cell carcinoma
por: Liu, Qi-Wei, et al.
Publicado: (2022)

Suppression of the long non-coding RNA MALAT-1 impairs the growth and migration of human tongue squamous cell carcinoma SCC4 cells
por: Han, Xu, et al.
Publicado: (2018)

DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression via inhibition of miR-432-5p
por: Xu, Tao, et al.
Publicado: (2020)

IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway
por: Yuan, Shyng-Shiou F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_blum7b3p18q2sv7ja1gcders4t